A
A

Ageas

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

JPM stays upbeat on European insurance into 2024

BUZZ-JPM stays upbeat on European insurance into 2024 ** J.P.Morgan remains positive on European insurance in 2024, citing peak yields, no threat from peak pricing, earnings growth, and benign credit risk ** The broker says peak yields are likely to be a net positive, especially for high capital return stocks such as UK life and Benelux names, addi
A
A
A
A
B
H
J
L
L
P
S
S
A
P
S
Z

3i Group, Phoenix, Zealand Pharma

EUROPE RESEARCH ROUNDUP- 3i Group, Phoenix, Zealand Pharma Dec 6 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including 3i Group, Phoenix, and Zealand Pharma, on Wednesday. HIGHLIGHTS * 3i Group III.L : RBC initiates coverage with outperform rating; target price 2,550p * H&M HMb.ST : Deutsche Bank cuts to sell from hold * Phoenix PHNX.L : JP Morgan raises target price to 415p from 400p * Tesco TSCO.L : Bernstein raises target price to 330p
3
A
C
C
C
D
D
E
F
H
I
K
L
M
P
R
A
H
A
D
N
P

AstraZeneca, Barclays, BASF SE

EUROPE RESEARCH ROUNDUP-AstraZeneca, Barclays, BASF SE Nov 27 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including AstraZeneca, Barclays, and BASF SE on Monday. HIGHLIGHTS * AstraZeneca AZN.L : Jefferies cuts target price to 12500p from 13000p * Barclays BARC.L : Jefferies cuts target price to 230p from 300p * BASF SE BASFn.DE : Morgan Stanley cuts to underweight from equalweight * Elior ELIOR.PA : Deutsche Bank raises to buy from hold
A
A
A
A
A
A
B
B
B
B
B
B
B
B
C
D
D
E
E
E
F
G
H
I
A
H
A
D
I

Ageas jumps as investor day allays China concerns

BUZZ-Ageas jumps as investor day allays China concerns ** Shares in Ageas AGES.BR are up 3% after the Belgium-based insurer's investor day helped soothe concerns about China, aided by its UK turnaround and confirmed 2023 guidance ** The company on Tuesday reaffirmed its 2023 outlook for a net operating result at the top end of its EUR 1.1-1.2 bln (
A

French and Benelux stocks-Factors to watch

French and Benelux stocks-Factors to watch Nov 22 (Reuters) - Below are company-related news and stories from France and Benelux which could have an impact on the region's markets or individual stocks. ISRAEL/HAMAS: Israel's government and Hamas agreed on Wednesday to a four-day pause in fighting to allow the release of 50 hostages held in Gaza in exchange for 150 Palestinians imprisoned in Israel, and the entry of humanitarian aid into the besieged enclave.
A
A
E
U
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.